Global biotechnology company CSL, headquartered in Melbourne, focuses on specialty biotherapies and supplies raw materials for many therapies.
2 reports, 2 independent
Updated Aug 16
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Global biotechnology company CSL, headquartered in Melbourne, focuses on specialty biotherapies and supplies raw materials for many therapies.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- CSL Limited, based in Melbourne, announced a successful collaboration between emeritus researcher Frazer and Jian Zhou on HPV research, leading to licensed IP for cancer prevention in Australia.Sub-event
CSL Limited operates through the CSL Behring segment.1 source
CSL, a Melbourne-based biotech firm, focuses on specialty therapies while Seqirus was formed from Novartis' vaccine business.1 source
Keep exploring
The entities involved
-
CSL Limited
Australian biotechnology company
-
Novartis
Swiss-American multinational pharmaceutical corporation
-
Melbourne
capital city of Victoria, Australia